IMPACT OF INDUCTION CHEMOTHERAPY ON NUTRITIONAL STATUS AND TREATMENT-RELATED COMPLICATIONS IN ADOLESCENTS AND YOUNG ADULTS (15–39 YEARS): A RETROSPECTIVE ANALYSIS
DOI:
https://doi.org/10.53555/n2wdae47Keywords:
Adolescents and Young Adults (AYA) oncology; Induction Chemotherapy; Nutritional Status; Oncology NutritionAbstract
Background: Adolescents and young adults (AYA) with cancer face unique challenges, including the impact of intensive chemotherapy on nutritional status. This study evaluates the effects of induction chemotherapy on nutritional parameters and associated complications in AYA patients with hematologic malignancies and Ewing sarcoma, comparing findings with international cohorts.
Methods: A retrospective analysis was conducted on 38 AYA patients (15–39 years) diagnosed with B-cell ALL, T-cell ALL, AML, and Ewing sarcoma. Anthropometric and biochemical parameters were assessed at diagnosis, post-induction, and six months post-therapy.
Results: Induction chemotherapy led to a significant decline in nutritional parameters across all cancer subtypes. The AML cohort exhibited the most pronounced deterioration. Patients showed marked reductions in weight, BMI, mid-arm circumference, and serum albumin after induction chemotherapy. Complication rates were higher in patients with greater nutritional declines, particularly in the AML group.
Conclusion: Induction chemotherapy in AYA patients leads to significant nutritional decline, especially in AML cases, which correlates with increased treatment-related complications. Early nutritional assessment and intervention should be integral to treatment protocols.
References
Per Ole I, Hansen DS, Smeland KB, et al. Nutritional status and treatment outcomes in adolescents and young adults with AML: a population-based study from Russia and Norway. Blood Adv. 2019;3(10):1561–1569.
2. Linga VG, Smith M, McWhorter JW. Nutritional surveillance and support in adolescent and young adult oncology patients. Ochsner J. 2012;12(3):189–195.
3. Schoonbeek L, de Vries MC, van den Berg MMGA, et al. Malnutrition and the pharmacokinetics of chemotherapy: a systematic review. Clin Nutr. 2021;40(4):1474–1488.
4. Malihi Z, Rangan AM, Tapsell LC, et al. Dietary intake and treatment-related outcomes in children with cancer: a prospective cohort study. Clin Nutr ESPEN. 2019;30:71–78.
5. Liu Y, Liu Q, Yuan B, et al. Malnutrition is an independent risk factor for overall survival in adult patients with acute myeloid leukemia. Leuk Res. 2021;104:106558.
6. Al-Nawakil C, Dufresne A, Vassal G. Nutrition in adolescent and young adult cancer patients: what do we know? Pediatr Blood Cancer. 2020;67(5):e28263.
7. Scheede-Bergdahl C, Gabrys T, Cormie P, et al. Improving nutrition in adolescents and young adults with cancer: The INAYA study. Support Care Cancer. 2020;28(9):4089–4098.
8. Landry L, Cheung WY, Xu Y, et al. Food insecurity in adolescent and young adult cancer survivors: a narrative review and call to action. J
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Population Therapeutics and Clinical Pharmacology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.